Nonbinding futility rule [Two-Stage / GS Designs]

posted by d_labes  – Berlin, Germany, 2018-06-13 18:59 (2921 d 04:52 ago) – Posting: # 18900
Views: 22,041

Dear Ben,

❝ General remark here: In your example we see that BE has not been achieved only marginally. The Repeated CI is (0.79215, 0.99993). Even though the power of stage 1 is large enough so that we formally conclude futility, one could question whether it is really a good idea to stop the trial due to futility ...


If I see it correctly that's called in Maurer et al. "futility rule can be applied in a nonbinding manner, ie, it can be used as guidance but must not necessarily be followed." (page 19, bottom)
How to obtain a sample size number for the second stage if we want to do so?

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
250 visitors (0 registered, 250 guests [including 154 identified bots]).
Forum time: 23:51 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5